Author

Peggy Suzanne

Normandie UniversitéORCID 0000-0002-6080-8306Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Assay:organoid / primary culture· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Patrick DallemagneiD· 2 shared Anne Elisabeth MercieriD· 1 shared Anne Sophie Voisin‐ChiretiD· 1 shared Aurore M. M. Dupuy· 1 shared Bénédicte Elena‐HerrmanniD· 1 shared Camille E. Tessier· 1 shared Camille El Harrif· 1 shared Cécile Cottet‐RousselleiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Patrick DallemagneORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integrative in silico and experimental identification of non-covalent UBE2N inhibitors enhancing PARP inhibitor sensitivity

Côme Ghadi, Shafi Ullah Khan, Léonie Ibazizene, Florian Schwalen, Charline Kieffer, Peggy Suzanne, Julie Jaouen, Hassiba Bouafia, Xavier Thuru, Marie Cornu, Cédric Lecoutey, Matthieu Meryet‐Figuière, Anne Sophie Voisin‐Chiret, Louis‐Bastien Weiswald, Jana Sopková‐de Oliveira Santos

The paper identifies two non-covalent UBE2N inhibitors, CERMN-2 and CERMN-16, which enhance PARP inhibitor sensitivity in ovarian cancer cells.

European Journal of Medicinal Chemistry Reports · Jul 30, 2026Peer-reviewedCancer Biology

Preventing neuropathy and improving anti-cancer chemotherapy with a carbazole-based compound

Lauriane Bosc, Maria Elena Pero, David Balayssac, Nathalie Jacquemot, Jordan Allard, Peggy Suzanne, Julien Vollaire, Cécile Cottet‐Rousselle, Sophie Michallet, Joran Villaret, Sakina Torch, Sumari Marais, Bénédicte Elena‐Herrmann, Uwe Schlattner, Anne Elisabeth Mercier, , Laurence Lafanéchère

This paper introduces Carba1, a carbazole-based compound that prevents chemotherapy-induced neuropathy without reducing cancer drug efficacy.

Science Advances · Oct 29, 2025Peer-reviewedCancer Biology

Primary cilia promote EMT-induced triple-negative breast tumor heterogeneity and resistance to therapy

Camille E. Tessier, Jennifer Derrien, Aurore M. M. Dupuy, Thomas Pelé, Martin Moquet, Julie Roul, Elise Douillard, Camille El Harrif, Xavier Pinson, Matthieu Le Gallo, Florence Godey, Patrick Tas, Roselyne Viel, Eloïse M. Grasset, Claude Prigent, , Vincent J. Guen

This study shows primary cilia in TNBC cells contribute to chemoresistance by supporting EMT-driven heterogeneity and stemness, and inhibiting ciliogenesis reduces this resistance.

EMBO Molecular Medicine · Aug 26, 2025Peer-reviewedCancer Biology